Status:
UNKNOWN
Reduction or Extension of COnduction Time With Ventricular Electromechanical Remodeling (RECOVER)
Lead Sponsor:
Samsung Medical Center
Collaborating Sponsors:
Abbott Medical Devices
Conditions:
Heart Failure
Eligibility:
All Genders
19+ years
Brief Summary
This prospective multicenter registry study aims to detect the serial changes in ventriculo-ventricular conduction times according to cardiac-resynchronization therapy response.
Eligibility Criteria
Inclusion
- meeting the current ESC or ACCF/AHA/HRS Class I or Class IIa indications for cardiac-resynchronization (CRT) implant
Exclusion
- Myocardial infarction, unstable angina within 40 days prior the enrollment
- Recent cardiac revascularization in the 4 weeks prior to the enrollment or planned for the 3 months following
- Cerebrovascular accident (CVA) or transient ischemic attack (TIA) in the 3 months prior to the enrollment
- Primary valvular disease requiring surgical correction
- Pregnant or are planning during the duration of the investigation
- Status 1 candidate for cardiac transplantation or consideration for transplantation over the next 12 months
- Post-cardiac transplantation
- Life expectancy \< 12 months
- Currently participating in any other clinical investigation except for observational registry
Key Trial Info
Start Date :
July 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 20 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04397224
Start Date
July 20 2018
End Date
July 20 2024
Last Update
June 30 2021
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Sejong General Hospital
Bucheon-si, South Korea
2
Samsung Changwon Medical Center
Changwon, South Korea
3
Chungnam National University Hospital
Daejeon, South Korea
4
Eulji University Hospital
Daejeon, South Korea